Strategies to Reverse Endothelial Progenitor Cell Dysfunction in Diabetes

Overview

Journal Exp Diabetes Res

Specialty Endocrinology

Date 2012 Apr 5

PMID 22474422

Citations 20

Authors

Alessandra Petrelli

Raffaele Di Fenza

Michele Carvello

Francesca Gatti

Antonio Secchi

Paolo Fiorina

Affiliations

Soon will be listed here.

Abstract

Bone-marrow-derived cells-mediated postnatal vasculogenesis has been reported as the main responsible for the regulation of vascular homeostasis in adults. Since their discovery, endothelial progenitor cells have been depicted as mediators of postnatal vasculogenesis for their peculiar phenotype (partially staminal and partially endothelial), their ability to differentiate in endothelial cell line and to be incorporated into the vessels wall during ischemia/damage. Diabetes mellitus, a condition characterized by cardiovascular disease, nephropathy, and micro- and macroangiopathy, showed a dysfunction of endothelial progenitor cells. Herein, we review the mechanisms involved in diabetes-related dysfunction of endothelial progenitor cells, highlighting how hyperglycemia affects the different steps of endothelial progenitor cells lifetime (i.e., bone marrow mobilization, trafficking into the bloodstream, differentiation in endothelial cells, and homing in damaged tissues/organs). Finally, we review preclinical and clinical strategies that aim to revert diabetes-induced dysfunction of endothelial progenitor cells as a means of finding new strategies to prevent diabetic complications.

Citing Articles

Liraglutide Improves the Angiogenic Capability of EPC and Promotes Ischemic Angiogenesis in Mice under Diabetic Conditions through an Nrf2-Dependent Mechanism.

Yan X, Su Y, Fan X, Chen H, Lu Z, Liu Z Cells. 2022; 11(23).

PMID: 36497087 PMC: 9736458. DOI: 10.3390/cells11233821.

Therapies Based on Adipose-Derived Stem Cells for Lower Urinary Tract Dysfunction: A Narrative Review.

Liu M, Chen J, Cao N, Zhao W, Gao G, Wang Y Pharmaceutics. 2022; 14(10).

PMID: 36297664 PMC: 9609842. DOI: 10.3390/pharmaceutics14102229.

Hydrogel Dressings for Chronic Wound Healing in Diabetes: Beyond Hydration.

Hartmeier P, Pham N, Velankar K, Issa F, Giannoukakis N, Meng W J Pharm Drug Deliv Res. 2022; 10(1).

PMID: 36110983 PMC: 9473423.

Elucidation of endothelial progenitor cell dysfunction in diabetes by RNA sequencing and constructing lncRNA-miRNA-mRNA competing endogenous RNA network.

Wan G, Xu Z, Xiang X, Zhang M, Jiang T, Chen J J Mol Med (Berl). 2022; 100(11):1569-1585.

PMID: 36094536 DOI: 10.1007/s00109-022-02251-x.

The Inhibitory Effect of Regulatory T Cells on the Intimal Hyperplasia of Tissue-Engineered Blood Vessels in Diabetic Pigs.

Guo F, Ren Z, Liu D, Wang L, Hou X, Chen W Front Bioeng Biotechnol. 2022; 10:929867.

PMID: 35957644 PMC: 9360552. DOI: 10.3389/fbioe.2022.929867.

References

Stefano V, Cencioni C, Zaccagnini G, Magenta A, Capogrossi M, Martelli F . p66ShcA modulates oxidative stress and survival of endothelial progenitor cells in response to high glucose. Cardiovasc Res. 2009; 82(3):421-9. DOI: 10.1093/cvr/cvp082. View

Heissig B, Hattori K, Dias S, Friedrich M, Ferris B, Hackett N . Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell. 2002; 109(5):625-37. PMC: 2826110. DOI: 10.1016/s0092-8674(02)00754-7. View

Schomig K, Busch G, Steppich B, Sepp D, Kaufmann J, Stein A . Interleukin-8 is associated with circulating CD133+ progenitor cells in acute myocardial infarction. Eur Heart J. 2006; 27(9):1032-7. DOI: 10.1093/eurheartj/ehi761. View

Ceradini D, Yao D, Grogan R, Callaghan M, Edelstein D, Brownlee M . Decreasing intracellular superoxide corrects defective ischemia-induced new vessel formation in diabetic mice. J Biol Chem. 2008; 283(16):10930-8. PMC: 2447622. DOI: 10.1074/jbc.M707451200. View

Raemer P, Haemmerling S, Giese T, Canaday D, Katus H, Dengler T . Endothelial progenitor cells possess monocyte-like antigen-presenting and T-cell-co-stimulatory capacity. Transplantation. 2009; 87(3):340-9. DOI: 10.1097/TP.0b013e3181957308. View

Fadini G, Baesso I, Albiero M, Sartore S, Agostini C, Avogaro A . Technical notes on endothelial progenitor cells: ways to escape from the knowledge plateau. Atherosclerosis. 2008; 197(2):496-503. DOI: 10.1016/j.atherosclerosis.2007.12.039. View

Fadini G, Agostini C, Sartore S, Avogaro A . Endothelial progenitor cells in the natural history of atherosclerosis. Atherosclerosis. 2007; 194(1):46-54. DOI: 10.1016/j.atherosclerosis.2007.03.046. View

Humpert P, Djuric Z, Zeuge U, Oikonomou D, Seregin Y, Laine K . Insulin stimulates the clonogenic potential of angiogenic endothelial progenitor cells by IGF-1 receptor-dependent signaling. Mol Med. 2008; 14(5-6):301-8. PMC: 2255559. DOI: 10.2119/2007-00052.Humpert. View

Ceradini D, Kulkarni A, Callaghan M, Tepper O, Bastidas N, Kleinman M . Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med. 2004; 10(8):858-64. DOI: 10.1038/nm1075. View

10.

Aicher A, Heeschen C, Mildner-Rihm C, Urbich C, Ihling C, Technau-Ihling K . Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med. 2003; 9(11):1370-6. DOI: 10.1038/nm948. View

11.

Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M . Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med. 1999; 5(4):434-8. DOI: 10.1038/7434. View

12.

Walther C, Gaede L, Adams V, Gelbrich G, Leichtle A, Erbs S . Effect of increased exercise in school children on physical fitness and endothelial progenitor cells: a prospective randomized trial. Circulation. 2009; 120(22):2251-9. DOI: 10.1161/CIRCULATIONAHA.109.865808. View

13.

Baumgartner I, Pieczek A, Manor O, Blair R, Kearney M, Walsh K . Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation. 1998; 97(12):1114-23. DOI: 10.1161/01.cir.97.12.1114. View

14.

Hill J, Zalos G, Halcox J, Schenke W, Waclawiw M, Quyyumi A . Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med. 2003; 348(7):593-600. DOI: 10.1056/NEJMoa022287. View

15.

Thum T, Fraccarollo D, Schultheiss M, Froese S, Galuppo P, Widder J . Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes. Diabetes. 2007; 56(3):666-74. DOI: 10.2337/db06-0699. View

16.

Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T . Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997; 275(5302):964-7. DOI: 10.1126/science.275.5302.964. View

17.

Prater D, Case J, Ingram D, Yoder M . Working hypothesis to redefine endothelial progenitor cells. Leukemia. 2007; 21(6):1141-9. DOI: 10.1038/sj.leu.2404676. View

18.

Segal M, Shah R, Afzal A, Perrault C, Chang K, Schuler A . Nitric oxide cytoskeletal-induced alterations reverse the endothelial progenitor cell migratory defect associated with diabetes. Diabetes. 2005; 55(1):102-9. View

19.

Fadini G, Boscaro E, Albiero M, Menegazzo L, Frison V, De Kreutzenberg S . The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alpha. Diabetes Care. 2010; 33(7):1607-9. PMC: 2890368. DOI: 10.2337/dc10-0187. View

20.

Hollenberg N, Stevanovic R, Agarwal A, Lansang M, Price D, Laffel L . Plasma aldosterone concentration in the patient with diabetes mellitus. Kidney Int. 2004; 65(4):1435-9. DOI: 10.1111/j.1523-1755.2004.00524.x. View